Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2008
07/02/2008EP1939205A1 Tricyclic compound
07/02/2008EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1938798A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
07/02/2008EP1937688A1 Imidazo benzodiazepine derivatives
07/02/2008EP1937687A1 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE
07/02/2008EP1937686A1 New anti-malaria derivatives of 4-aminoquinoline
07/02/2008EP1937685A1 Tetrahydro-pyrrolizinone compounds as lfa-i mediators
07/02/2008EP1451155B1 Compositions, methods and kits pertaining to luminescent compounds
07/02/2008EP1200091B1 Pharmaceutical composition comprising tadalafil
07/02/2008CN101213197A Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists
07/02/2008CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
07/02/2008CN101212903A Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
07/02/2008CN100398648C Probe foranalysis of nucleic acids
07/02/2008CN100398542C Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses
07/02/2008CN100398541C Pyrimidinone derivatives and 3-keto ester
07/02/2008CN100398539C Synthesis of heteroaryl acetamides
07/02/2008CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
07/01/2008US7394096 Field effect transistor and method of manufacturing the same
07/01/2008US7393956 Dimerization of naphthalene-1,8-dicarboximide in aprotic solvent and alkali base
07/01/2008US7393954 Process for the production of pentostatin aglycone and pentostatin
07/01/2008US7393953 Polymeric acyl derivatives of indoles
07/01/2008US7393853 9-(2-Oxo-2-phenyl-ethyl)-2-(4-pyridinyl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta and tau protein kinase inhibitor; neurodegenerative diseases: Alzheimer's disease, vascular dementia; acute stroke, retinopathy, glaucoma, alopecia
07/01/2008US7393848 Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
07/01/2008US7393847 Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
07/01/2008US7393404 Color filter, image display device and information communication equipment; pigment dispersing ability, transparency, fluidity and storage stability
06/2008
06/26/2008WO2008076883A2 Triazine derivatives and their therapeutical applications
06/26/2008WO2008076810A2 Azabicyclic heterocycles as cannabinoid receptor modulators
06/26/2008WO2008076425A1 Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
06/26/2008WO2008075955A2 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles
06/26/2008WO2008075110A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
06/26/2008WO2008075109A1 Substituted piperidines having protein kinase inhibiting activity
06/26/2008WO2008075007A1 Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
06/26/2008WO2008074788A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
06/26/2008WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008074676A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors
06/26/2008WO2008074512A1 Process for the preparation of sildenafil
06/26/2008WO2008074253A1 Pyridazinoindole derivatives, their preparation and therapy use
06/26/2008WO2008074194A1 A process for the preparation of sildenafil and the intermediates thereof
06/26/2008WO2008058126A3 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
06/26/2008WO2008057512A3 Imidazopyrazines as protein kinase inhibitors
06/26/2008WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives
06/26/2008WO2008021851A3 Novel compounds as antagonists or inverse agonists for opioid receptors
06/26/2008US20080154033 isolating a mesoporphyrin formate and converting it to a metal mesoporphyrin halide such as tin mesoporphyrin chloride, through metal insertion
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153864 Spiroazabicyclic Heterocyclic Compounds
06/26/2008US20080153854 Novel fused heterocycles and uses thereof
06/26/2008US20080153828 Imidazopyridazine Compounds
06/26/2008US20080153809 Novel amides useful for treating pain
06/26/2008US20080153807 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions
06/26/2008US20080153804 Gamma D-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
06/26/2008US20080153802 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein
06/26/2008US20080152702 Improved blood circulation lifetime of drug-carrying liposomes having a surface coating of releasable hydrophilic polymer covalently and reversibly linked to an phospholipid or polypeptide through a dithiobenzyl linkage
06/26/2008DE102006062203A1 Substituierte 5H-Pyrimido[5,4-b]indole als Induktoren der Apoptose bei B-CLL Zellen Substituted 5H-pyrimido [5,4-b] indoles as inducers of apoptosis in B-CLL cells
06/26/2008CA2673451A1 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
06/26/2008CA2672893A1 Triazine derivatives and their therapeutical applications
06/26/2008CA2672841A1 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety
06/26/2008CA2672719A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors
06/26/2008CA2672521A1 Pyrazole derivatives as protein kinase inhibitors
06/26/2008CA2671525A1 Indolylmaleimide derivatives
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues.
06/25/2008EP1934257A2 Proteasome inhibiting beta lactam compounds
06/25/2008EP1934227A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
06/25/2008EP1934226A2 Highly pure pemetrexed diacid and processes for the preparation thereof
06/25/2008EP1934225A1 Pyrazolo [1,5-a] pyrimidines as protein kinase inhibitors
06/25/2008EP1934224A1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors for the treatment of cancer
06/25/2008EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
06/25/2008EP1934222A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists
06/25/2008EP1934214A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
06/25/2008EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
06/25/2008EP1933842A2 5-lipoxygenase-activating protein (flap) inhibitors
06/25/2008EP1811994B1 Novel derivatives of porphyrin, particularly chlorins and bacteriochlorins, and uses thereof in photodynamic therapy
06/25/2008EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders
06/25/2008EP1608657A4 Water-soluble mono-pegylated tetrapyrrole derivatives for photodynamic therapy and method of production
06/25/2008CN101208342A Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
06/25/2008CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
06/25/2008CN101208289A Method for production of substituted phenylmalonate esters intermediate compounds and the use thereof for the production of 5, 7-dihydroxy-6-(2,4,6-trifluorophenyl)-(1,2,4)triazolo(1,5-a) pyrimidines
06/25/2008CN100397678C Electronic device containing organic compound with P-type semi-conductr character
06/25/2008CN100396684C Aluminium and hexa methylene tetramine composite and application thereof
06/25/2008CN100396683C Pyrrolobenzodiazepines
06/24/2008US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
06/24/2008US7390820 Substituted quinolinone derivatives and methods of use
06/24/2008US7390815 Pyrazole compounds useful as protein kinase inhibitors
06/24/2008US7390814 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
06/24/2008US7390809 7-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-2-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[1,5- alpha ]pyrazine, hydrochloride; antidiabetic agent, non-insulin dependent diabetes; synergistic mixture with other active ingredients
06/24/2008US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
06/24/2008US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents
06/24/2008US7390797 Fused indazole compounds
06/24/2008US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid
06/19/2008WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system
06/19/2008WO2008072779A1 Quinoxaline derivative
06/19/2008WO2008072778A1 Therapeutic agent for urinary tract disease
06/19/2008WO2008072758A1 Metal complex and use thereof
06/19/2008WO2008072682A1 Imidazo[1,2-b]pyridazine derivative
06/19/2008WO2008072586A1 Material for organic electroluminescent device and organic electroluminescent device
06/19/2008WO2007045060A8 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production
06/19/2008US20080146799 Processes for preparing intermediates of pemetrexed
06/19/2008US20080146796 reacting rapamycin with an alkyl triflate, purifying the resulting reaction product with a normal phase chromatograph and further purifying with a reverse phase chromatography